Suppr超能文献

微乳液冷稀释技术制备的硬脂酰壳聚糖纳米粒。

Stearoyl-Chitosan Coated Nanoparticles Obtained by Microemulsion Cold Dilution Technique.

机构信息

University of Turin, Dipartimento di Scienza e Tecnologia del Farmaco, via Giuria 9, Torino 10125, Italy.

Amedeo Avogadro University of Eastern Piedmont, Dipartimento di Scienze del Farmaco, Largo Donegani 2/3, Novara 28100, Italy.

出版信息

Int J Mol Sci. 2018 Nov 30;19(12):3833. doi: 10.3390/ijms19123833.

Abstract

Chitosan is an excipient which has been studied thoroughly in research works thanks to its positive characteristics such as muco-adhesiveness and ability to open epithelial-tight-junctions. In this article, lipophilic stearoyl chitosan (ST-CS) was synthetized in order to anchor this polymer to lipid nanoparticles and prepare ST-CS-coated nanoparticles (ST-CS-NP) using the microemulsion cold dilution technique. Curcumin (CURC) was used as model drug. CURC-ST-CS-NP were characterized by dimensional analysis, zeta potential, drug entrapment, drug release; tested in vitro on Human Umbilical Vein Endothelial Cell (HUVEC) cells to study its cytotoxicity and on human pancreatic cancer cells (PANC-1) to determine inhibition ability; tested in rats to determine CURC blood profiles and biodistribution. CURC-ST-CS-NP had mean diameters in the range 200⁻400 nm and CURC entrapment up to 73%. These systems did not show cytotoxicity on HUVEC cells at all tested dilutions and revealed to be more effective than free CURC solution on PANC-1 cells at 5 and 10 µM CURC. Blood profile studies evidenced as CURC entrapment in NP prolonged the permanence of drug in the systemic circulation compared to CURC solution due to a certain stealth property of NP, probably attributable to hydrophilic chitosan coating. Biodistribution studies showed a smaller CURC concentration in RES organs when CURC-ST-CS-NP were administered.

摘要

壳聚糖是一种赋形剂,由于其具有黏膜黏附性和开放上皮紧密连接的能力等积极特性,在研究工作中得到了广泛研究。在本文中,合成了亲脂性硬脂酰壳聚糖(ST-CS),以便将该聚合物锚定到脂质纳米颗粒上,并使用微乳液冷稀释技术制备 ST-CS 涂层纳米颗粒(ST-CS-NP)。姜黄素(CURC)被用作模型药物。通过尺寸分析、Zeta 电位、药物包封率、药物释放率对 CURC-ST-CS-NP 进行了表征;在人脐静脉内皮细胞(HUVEC)细胞上进行体外测试,以研究其细胞毒性,在人胰腺癌细胞(PANC-1)上进行测试,以确定抑制能力;在大鼠体内进行测试,以确定 CURC 的血液特征和生物分布。CURC-ST-CS-NP 的平均粒径在 200⁻400nm 范围内,CURC 包封率高达 73%。这些系统在所有测试稀释度下对 HUVEC 细胞均无细胞毒性,并且在 5 和 10µM CURC 时对 PANC-1 细胞的效果优于游离 CURC 溶液。血液特征研究表明,由于 NP 的某种隐形特性,可能归因于亲水性壳聚糖涂层,NP 中的 CURC 包封延长了药物在全身循环中的停留时间,从而延长了药物的滞留时间。与 CURC 溶液相比。当给予 CURC-ST-CS-NP 时,RES 器官中的 CURC 浓度较小。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08f6/6321505/cb47ad4d6d7e/ijms-19-03833-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验